Produced by the Royal College of Physicians of Edinburgh and Royal College of Physicians and Surgeons of Glasgow
References
- Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–12.
- Soriano JB, Maier WC, Egger P et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55:789–794.
- The Lung and Asthma Information Agency, St George’s University. The Burden of Lung Disease. 2nd Edition: London: British Thoracic Society; 2006.
- Poole PJ, Black N. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322:1271.
- Decramer M, Rutten-van Molken, M, Dekhuijzen R et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005; 365(9470):1552–60. Erratum in: Lancet 2005; 366:984.
- Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. In: The Cochrane Database of Systematic Reviews [internet]. Issue 2. Hoboken (NJ): John Wiley & Sons, Ltd.; 2005 [Art. No. CD000998].
- Lightowler JV, Wedzicha JA, Elliott MW, Ram FSF. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003; 326:185.